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Surgery for Morbid Obesity: A Continuing Challenge
Brack A. Bivins, MD,* Farouck N. Obeid, MD,* H. Mathilda Horst, MD,
and Victor J. Sorensen, MD*

M

orbid obesity is often defined as a body weight twice the
ideal weight as determined from insurance tables or 50 kg
(110 lb) or greater above the ideal for individuals taller than 152
cm (62 in) (1-3). Morbid obesity is associated with a variety of
health problems including hypertension, diabetes meUitus, degenerafive joint disease, and respiratory insufficiency (4-10). In
addition to the morbidity implied by obesity-related disease,
Drenick et al ( I I ) documented that an age-specific increased
mortality is associated with obesity. The underlying etiology
of obesity is not clear and has been variously ascribed to
sociologic, environmental, psychologic, genetic, and biochemical factors. Regardless of cause, obesity is a disease that is
not easily managed. Medical management through diet has been
successful in less than 5% of morbidly obese pafients (3,12-15).
Recognition of the health implications of morbid obesity and
ofthe inadequacy of dietary management has prompted trials
of various surgical approaches to weight control (Table 1)
(1,16-34). The multiplicity of surgical procedures suggests that
no single procedure completely fulfills the following criteria for
satisfactory surgically induced weight loss and control; 1) early
and consistent weight loss, 2) sustained long-term weight control, 3) minimal operafive morbidity and mortality, 4) minimal
long-term adverse sequelae, 5) minimally subject to patient
manipulation, and 6) an operation which is easily dismantled
(1,16).
Three procedures, jejunoileal bypass, gastric bypass, and
gastroplasty, have been widely used. Each of these procedures
has significant associated problems which are illustrated in the
following case examples.

On admission she appeared to be a healthy young woman. Her vital
signs were normal, and physical examination was remarkable only for
moderate obesity and a well-healed midline abdominal incision. Chest
x-ray and routine admission laboratory studies including a liver profile
were normal.
On the day following admission she underwent take-down of her jejunoileal bypass with conversion to a Roux-en-y ga.stric bypass (35).
Postoperatively she did well and was able to take liquids on the fifth day
and solids on the sixth day.
In clinic follow-up six months later, she had lost 12.2 kg (27 lb),
weighing 75.1 kg (167 lb). She reported no recurrence of her abdominal cramping, nausea, and diarrhea. She had no recurrence of nephrolithiasis. She also noted less fatigue and claimed an increased sense
of well-being.

Comment
Although this young woman initially did well following her jejunoileal bypass, eight years postoperatively she exhibited recurrent
nephrolithiasis, abdominal pain, nausea, diarrhea, and fatigue. These
adverse sequelae of small bowel bypass became apparent years after the
original procedure. Other patients have had liver failure more than 15

Table 1
Surgical Approaches to Weight Reduction and Control*
Rationale
Reduction of appetite

Surgical Technique
Hypothalamic lesion (25,26)
Ileal transposition (1)

Reduction of oral intake

Dental occlusion (27)

Reduction of gastric volume

Gastric bypass (18,21)
Gastroplasty (22-24)
Gastric wrap (16,28)
Intragastric balloon (29-31)

Reduction of absorption

Jejunoileal bypass (17,19,32)
Biliointestinal bypass (20)
Biliopancreatic bypass (33)

Increased transit time

Tmncal vagotomy (34)

Jejunoileal Bypass
Case 1
This 23-year-old white female was admitted for elective conversion
of jejunoileal bypass to Roux-en-y gastric bypass. She had undergone
jejunoileal bypass at age 15 when she was 162.5 cm (64 in) tall and
weighed 103.5 kg (230 lb). Approximately one year following the jejunoileal bypass, .she had her first episode of nephrolithiasis. She had
maintained a weight of 64.4 to 71.1 kg (143 to 158 lb) for several years.
In the 18 months prior to the current admission she had two episodes of
nephrolithiasis and had experienced increasing difficulty with crampy
abdominal pain, nausea, diarrhea, and fatigue. She began to gain
weight recendy and was admitted weighing 87.3 kg (194 lb).
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Fig I—Diagram of Roux-en-y gastric bypass.

Fig 2—Diagram of vertical-banded

gastroplasty.

years after jejunoileal bypass. Such cases emphasize that patients who
have undergone jejunoileal bypass are at lifelong risk for metabolic sequelae (1,17,36). In this case, conversion to Roux-en-y gastric bypass
after take-down of the jejunoileal bypass provided further moderate
weight loss and control (35).

anastomosis is the major operative complication of gastric bypass
(2,18,37,38). Such a leak leading to a subphrenic abscess is a devastating complication in the morbidly obese and may require multiple operations and extremely prolonged hospitalization. However, the benefits of
successful weight reduction can be substantial, as in this patient who
had amelioration of her hypertension and diabetes (4,8).

Gastric Bypass
Case 2
This morbidly obese 52-year-old white female was admitted for elective
Roux-en-y gasttic bypass (Fig 1). She had a long history of obesity and
unsuccessful attempts at dietary management. Admission weight and
height were 133.2 kg (2961b) and 157.5cm(62 in). Her obesity was complicated by hypertension, coronary artery disease, diabetes, and asthma.
Her medications at admission included hydrochlorothiazide, chlorpropamide, aminophylline, propranolol, dipyridamole, and papaverine.
On admission she was morbidly obese but in no acute distress. Her
vital signs were normal including a blood pressure of 122/74 mm Hg
(on medication). Her physical examination was unremarkable except
for her obvious obesity.
On the day following admission she underwent Roux-en-y gastric
bypass. Her postoperative course was complicated on the third day by
tachycardia (> 120 beats/min), fever (39.5°C [103.1°F]), and left shoulder
pain. An upper gastrointestinal series with water-soluble contrast demonstrated an anastomotic leak at the gastrojejunostomy communicating with
the left subphrenic space. She was reoperated on for closure ofthe leak,
drainage of the subphrenic abscess, and placement of a feeding gastrostomy in the distal excluded gastric pouch. The abdominal wound was
packed open. Immediately following this reoperative procedure she exhibited signs of sepsis and required six days of respirator support. As her
sepsis cleared she was able to be weaned from the respirator but required
ongoing wound care and nutritional support. By the 50th postoperative
day, the repaired leak was demonstrated to be sealed by upper gastrointestinal series, and she was started on oral feedings. She was discharged 56
days following the initial procedure.
On clinic follow-up 18 months later, she had lost 45 kg (100 lb), weighing 88.2 kg (196 Ib). She required no medications for her hypertension or
diabetes but continued to take dipyridamole for prophylaxis. She reported
increased physical activity associated with reduced body weight.
Comment
This patient's clinical course demonstrates both the principal risk and
some of the benefits of gastric bypass. Leakage from the gastrojejunal
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Gastroplasty
Case 3
This 41-year-old white female was admitted for elective conversion
of her vertical-banded gastroplasty to a Roux-en-y gastric bypass (Fig
2). Three years previously she had undergone gastroplasty when she
weighed 137.3 kg (305 lb) and was 167.6 cm (66 in) tall. At thattimeher
obesity was complicated by hypertension, and she required two medications to control her blood pressure. She had lost 22.5 kg (50 lb) following gastroplasty but regained all the weight over the past six
months, retuming to her preoperative weight. An upper gastrointestinal
series obtained on an outpatient basis demonstrated disruption of the
vn outpatient basis demonstrated disruption ofthe
vertical staple line of her gastroplasty.
On admission she was morbidly obese but in no acute distress. Her
vital signs were remarkable for a blood pressure of 144/100 mm Hg.
Her physical examination was remarkable only for her obesity and the
presence of a well-healed midline abdominal incision. All routine preoperative test results were normal.
On the day following admission she underwent conversion ofher vertical-banded gastroplasty to a Roux-en-y gastric bypass. She did well
postoperatively and began taking oral liquids on the fifth day and solids
on the sixth day. She was discharged on the seventh postoperative day.
On clinic follow-up one year later, she had lost 47.3 kg (105 lb),
weighing 90 kg (200 lb). Her blood pressure was normal without medication. She reported increased energy and increased activity level.
Comment
This patient's clinical course illustrates the principal complication of
the gastroplasty procedures: the failure of weight control (39,40). In
this case the cause of weight loss failure was disruption of the gastroplasty staple line. In other patients the cause of weight loss failure
has been dilatation of the gastric pouch itself orof the outlet of the gastric pouch. Regardless of cause, failure of weight control has been
reported in up to 40% of patients three years postgastroplasty (39,40).
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Discussion
In 1954, Kremen et al (41) suggested jejunocolostomy as a
means of shortening the small bowel to create a situation of controlled malabsorption. An unacceptably high incidence of complications with jejunocolostomy led Sherman et al (42) in 1965 to
recommend that the proximal jejunum be anastomosed to the distal
ileum above the ileocecal valve. In 1973, Riyne et al (19) published
their results with small bowel bypass where the proximal jejunum
had been transected 35 cm below the ligament of Treitz and the
proximal transected end anastomosed to the side ofthe ileum 10 cm
proximal to the ileocecal valve. Failure of some patients to lose
weight with this procedure was attributed to reflux of nunients into
the bypassed segment of the small bowel. In 1977, Scott and colleagues (32) proposed transection of the jejunum 30 cm distal to the
ligament of Treitz and transection of the ileum 15 cm proximal to
the ileocecal valve. The proximal end of the transected jejunum and
distal end ofthefi-ansectedileum were then anastomosed. The distal end ofthe transected jejunum and the bypassed bowel was oversewn and the distal portion was anastomosed to the colon, providing drainage ofthe bypassed segment. With various modifications,
usually in the amount of ileum preserved, this procedure became
the standard jejunoileal bypass.
Jejunoileal bypass, in its many modifications, attempted to
achieve weight loss and control by creating a condition of controlled malabsorption. Late metabolic complications resulfing
from malabsorption, such as intractable diarrhea, severe hepatic
dysfunction, cholelithiasis, and nephrolithiasis, pose the principal risks of jejunoileal bypass (Table 2) (1,17,36,43). These
and other sequelae have led to a virtual abandonment ofthis procedure as a means of weight control. Yet, as case 1 illustrates,
the problem of patients who have already undergone jejunoileal
bypass persists. These pafients are at lifelongriskfor complications of their jejunoileal bypass unless their bypass is reversed
(17,36). Since simple take-down of the jejunoileal bypass is
commonly associated with rapid and dramatic weight gain, synchronous conversion to a gastric restrictive procedure is advised
for maintenance of weight control, if the patient's condition will
tolerate reoperation (35).
Discouraged by the complications of jejunoileal bypass. Mason
(21) devised in 1969 a procedure to reduce the size of the stomach as
a means of limiting food intake. In this procedure the stomach was
transected, leaving a proximal pouch approximately 10% ofthe capacity of the normal stomach. This proximal pouch was anastomosed to a loop of jejunum, creating an opening of no greater
than 1.2 cm to impede gastric emptying. Mason's procedure has
undergone a series of modifications to where the standard gastric
bypass now consists of stapling the stomach without transection to
create a 30 to 45 cc proximal pouch and Roux-en-y gastrojejunostomy of 1 cm in diameter (2,18,44-46). Using this technique,
gastric bypass can achieve a sustained weight loss equivalent to that
of jejunoileal bypass (47,48).
Roux-en-y gastric bypass has evolved to become the "gold standard" for gastric restiictive procedures (18,44-46). The principal
problem with the gastric bypass is a leak at die gastrojejunal anastomosis (as in case 2) (18,44,45). Such leaks may result from poor
blood supply to the proximal pouch. Tachycardia (pulse > 120
beats/min), fever, and increasing leukocyte count occurring within
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Table 2
Complications Associated with Jejunoileal Bypass*
Fluid and electrolyte imbalance
Hepatic dysfunction
Nephrolithiasis
Intrinsic renal disease
Polyarthralgias
Specific absorptive defects
Excess flatulence
Easy fatigue
Cholelithiasis
Intussusception
Bypass enteritis
Colonic pseudoobstruction
Vitamin deficiencies
Immunosuppression
Carcinogenic potential
Abdominal pain
Diarrhea
Bone disease
•.See References 1, 17. and 43.

two to five days postoperatively suggest the presence of an
anastomotic leak. Water-soluble contrast studies of the upper gastrointestinal tract can verify the presence of the leak and determine
whether this leak is contained adjacent to the anastomosis or communicates with the subphrenic space (2,49). Subphrenic abscess
resulting from an anastomotic leak is a devastating complication in
the morbidly obese and may necessitate weeks or months of hospitalization for its resolution. Over time approximately 15% of patients are able to distend the gastric pouch or dilate the gastrojejunal
anastomosis sufficientiy to allow weight gain, although this weight
gain rarely reaches preoperative levels. The principal long-term
complication of gastiic bypass is anemia (37,44,45,50,51). A theoretical concem is that metaplasia of the excluded stomach could
predispose the patient to gastric cancer, but this has not been
observed clinically.
The technical difficulty in performing gastric bypass and the
concem about the excluded stomach have spawned a series of
procedures designed to create a restrictive pouch with gastric
continuity maintained. These procedures include horizontal
gastroplasty (Pace-Carey or Gomez) (22,23), vertical-banded
gastroplasty (Mason) (24), and a multitude of variations. The
vertical-banded gastroplasty is considered the standard gastroplasty (24).
All of these gastroplasty procedures fail to control weight
over time. Failure of weight control with the verfical-banded
gastroplasty (as in case 3) has been reported in up to 40% of
patients three years postoperatively (39,46,52).
Currenfiy, some preliminary conclusions about the surgical
approach to morbid obesity can be made;
1. Jejunoileal bypass is rarely indicated solely for weight control (17,36,46,47), even though some authors have suggested
that jejunoileal bypass may have a role as an intermediate procedure for the "massively" morbidly obese (> 270 kg [600 lb])
(17,47). In this rare circumstance, jejunoileal bypass would be
performed to achieve sufficient weight loss to allow a safe conversion to a gastric restrictive procedure.
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2. The current preferred approach to the operative control
of obesity is a gastric restrictive procedure (either gastric bypass
or gastroplasty). The Roux-en-y gastric bypass appears more
effective in maintaining weight loss than the gastroplasties
(40,46,53). However, Sugarman et al (54) suggested recently
that the morbidly obese can be classified preoperatively into
sweet versus nonsweet eaters and that the latter group may be
treated satisfactorily by gastroplasty. Choice of the appropriate
gastric procedure resides with the operating surgeon.
3. All other procedures for weight control should be considered experimental until sufficient experience with their use and
outcome can be evaluated. Operative procedures for weight loss
and control have been widely adopted before adequate evaluation of the potential for adverse sequelae was complete. For
example, thousands of patients underwent jejunoileal bypass
before evaluation proved that only approximately 30% of patients would have a satisfactory long-term outcome, that another
30% would have symptoms requiring medication, and that the
remainder would have life-threatening complications virtually
mandating reversal of the procedure (1,17,36,52). This experience should prompt caution in adopting innovative approaches
to surgical control of obesity without clear, supporting data.
4. Given the potential for problems with operations for
obesity, the decision to operate should not be undertaken lightly.
Although the primary criterion for patients undergoing a surgical procedure for weight control is the state of morbid obesity,
the patient should have no evidence of an endocrine cause of
obesity. In addition, the patient should have a long-term history
of obesity marked by weight loss and subsequent weight gain
over a period of years. Patients with concomitant diseases such
as diabetes, hypertension, or respiratory insufficiency who are
likely to benefit substantially from weight reduction are highly
suitable candidates.
Absolute contraindications to pertormance of an operation for
morbid obesity are illnesses such as cancer, symptomatic coronary artery disease, and end-stage renal disease which greatiy
reduce life expectancy and are not expected to be improved by
weight reduction. Psychiatric illness is not necessarily a contraindication. Patients who are incapacitated by their obesity
with respiratory failure (the Pickwickian syndrome) or immobilized due to their bulk are extremely high-risk candidates
for operation compared to the active, healthy morbidly obese
(1,2,18). In these pafients the decision to operate must be based
on a careful examination of the operative and postoperative risks
compared to the potential benefits (4,8).
The ideal surgical approach to weight control has not yet been
idenfified, and the procedures currently available are not without
risk. Balanced against the risks of operation are thoserisksof
morbid obesity and the potential benefits of weight reduction
and control. For patients with morbid obesity and its attendant
complications, the risks of operation may be justified. Such patients should be chosen carefully, informed fully, operated on
expertiy, and followed up for their lifetime.
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